Sultan Abdul-Jawad
E4tech (United Kingdom)(GB)BioNTech (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, HIV Research and Treatment, vaccines and immunoinformatics approaches, Immunotherapy and Immune Responses
Most-Cited Works
- → A dynamic COVID-19 immune signature includes associations with poor prognosis(2020)1,025 cited
- → Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study(2021)610 cited
- → HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation(2019)586 cited
- → The soluble isoform of CTLA‐4 as a regulator of T‐cell responses(2013)132 cited
- → Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients(2021)115 cited
- → Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection(2016)112 cited
- → Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis(2020)68 cited
- → Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines(2021)60 cited
- → Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition(2015)38 cited
- → Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer(2021)36 cited